U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214740) titled 'Study to Evaluate a Pegcetacoplan (Syfovre(R)) Prefilled Syringe' on Oct. 06.
Brief Summary: This is a phase 3, open-label study to evaluate the safety of pegcetacoplan in a prefilled syringe (PFS)
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Geographic Atrophy Secondary to Age-related Macular Degeneration
Intervention:
DRUG: APL-2, Pegcetacoplan
Complement (C3) Inhibitor
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Apellis Pharmaceuticals, Inc.
Disclaimer: Curated by HT Syndication....